NEUROBLASTOMA
Clinical trials for NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for childhood cancer tested, but study stopped early
Disease control TerminatedThis study tested a new drug combination (ribociclib plus topotecan and temozolomide) in children and young adults with neuroblastoma or other solid tumors that had come back or not responded to treatment. The goal was to find a safe dose and see if it could help control the canc…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New targeted radiation shows promise for tough childhood cancer
Disease control TerminatedThis study tested a radioactive drug called 67Cu-SARTATE in children with high-risk neuroblastoma, a serious nerve cell cancer. The goal was to find the safest dose and see if it shrinks tumors. The trial was stopped early, but results help guide future treatments.
Matched conditions: NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Tailored cancer cocktail fails to launch: neuroblastoma trial halted
Disease control TerminatedThis study aimed to give children with relapsed or hard-to-treat neuroblastoma a personalized treatment plan. Doctors would analyze the tumor's genes and pick a combination of targeted drugs to attack the specific mutations found. The trial was stopped early, so results are limit…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Yael P Mosse • Aim: Disease control
Last updated May 06, 2026 16:02 UTC